I'm LongbridgeAI, I can summarize articles.The Week
Mengniu Dairy (2319.HK) fell 3.67% this week to close at HK$22.04, while the Hang Seng Index dropped 5.65%, leaving Mengniu roughly 1.98 percentage points ahead of the benchmark. It was a four-day, up-then-down week: shares opened firm on Monday and closed at HK$23.10, touched a high of HK$23.38 on Tuesday, slipped to HK$22.76 on Wednesday, and sold off to end at the week’s low on Thursday. The final day’s volume jumped, wiping out most of the early-week gains with a weekly range of 6.82%.
Key Events
Mengniu appeared repeatedly on the new-highs list this week. Monday saw an intraday gain of over 4%, and the stock closed at a record high alongside CKI Holdings, Bank of China, and Midea. It pushed to another record high on Tuesday and hit a fresh 52-week high on Wednesday. Citi said the company maintains its full-year guidance and expects operating margin expansion to resume next year, and reiterated it as a top pick among Chinese consumer stocks. Friday brought an intraday drop of over 4%, mirroring the broader market pullback.
Analyst Ratings
Across 27 brokers covering Mengniu, 21 rate it buy and 6 rate it overweight, with no hold, underweight, or sell ratings. The consensus rating is strong buy, and the consensus target sits at HK$23.78, about 7.9% above the latest price of HK$22.04. Targets range from HK$20.003 to HK$27.245, a moderately wide spread. Mengniu ranks first among 24 companies in the packaged foods and meat industry.
The Week Ahead
Mengniu reports third-quarter fiscal 2026 results on Thursday, 26 November, before the market opens. With Citi noting that full-year guidance is unchanged, the focus will be on whether Q3 delivery stays consistent with that guidance and whether the expected operating margin recovery shows up in the numbers.
In Short
Mengniu hit record highs early in the week, then gave back those gains as the broader market pulled back, finishing at the week’s low but still ahead of the Hang Seng Index by nearly 2 percentage points. The sell-side picture is skewed positive—all 27 covering brokers rate it buy or overweight, with the consensus target about 7.9% above spot. The key test now is whether next week’s Q3 results can put the stock back on an upward path after this week’s sharp pullback.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
